Skip to main content
. 2023 Jun 20;10:1200145. doi: 10.3389/fmed.2023.1200145

Table 2.

Procedure-related outcomes.

Total (n = 47) Polyp size ≥15 mm (n = 7) Polyp size <15 mm (n = 40) p-value
R0 resection rate, n (%) 38 (80.9) 3 (42.9) 35 (87.5) <0.01
R1 resection rate, n (%) 3 (6.4) 2 (28.6) 1 (2.5)
Rx resection rate, n (%) 6 (12.8) 2 (28.6) 4 (10.0)
Muscle entrapment, n (%) 9 (19.1) 5 (71.4) 4 (10.0) <0.01
En bloc resection rate, n (%) 46 (97.9) 6 (85.7) 40 (100) 0.15
Piecemeal resection rate, n (%) 1 (2.1) 1 (14.3) 0
Technical success, n (%) 47 (100) 7 (100) 40 (100)
Median procedure time, seconds (range) 71 (42–607) 110 (69–379) 68 (42–607) 0.16
Histologic type, n (%) 0.12
Sessile serrated adenoma/polyps 6 (12.8) 2 (28.6) 4 (10.0)
Tubular adenoma 39 (83.0) 4 (57.1) 35 (87.5)
Tubulovillous adenoma 2 (4.3) 1 (14.3) 1 (2.5)
Villous adenoma 0 0 0
Intramucosal adenocarcinoma 0 0 0
Submucosal adenocarcinoma 0 0 0
Fluid infusion (mL), median (range) 50 (30–130) 70 (40–130) 50 (30–120) <0.01
Snare tip ablation, n (%) 13 (27.7) 3 (42.9) 10 (25.0) 0.38
Coagrasper use, n (%) 3 (6.4) 2 (28.6) 1 (2.5) 0.054
Endoscopic clipping, n (%) 0 0 0